|
Volumn 115, Issue 5, 2005, Pages 899-902
|
Prospective, randomized, controlled clinical trial of a novel matrix hemostatic sealant in patients with acute anterior epistaxis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
COLLAGEN;
HEMOSTATIC AGENT;
THROMBIN;
ADULT;
AGED;
BLEEDING;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
EPISTAXIS;
GEL;
HEMOSTASIS;
HUMAN;
MAJOR CLINICAL STUDY;
NOSE;
PATIENT SATISFACTION;
PHYSICIAN ATTITUDE;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
SAFETY;
VISUAL ANALOG SCALE;
ACUTE DISEASE;
AGED;
CROSS-OVER STUDIES;
EPISTAXIS;
FEMALE;
FOLLOW-UP STUDIES;
GELATIN SPONGE, ABSORBABLE;
HEMOSTASIS;
HEMOSTATIC TECHNIQUES;
HUMANS;
MALE;
PROSPECTIVE STUDIES;
QUESTIONNAIRES;
SEVERITY OF ILLNESS INDEX;
|
EID: 18044386166
PISSN: 0023852X
EISSN: None
Source Type: Journal
DOI: 10.1097/01.MLG.0000160528.50017.3C Document Type: Review |
Times cited : (85)
|
References (13)
|